Published in Virus Weekly, March 27th, 2001
"Studies showing that oxidative stress and iron may be important in the activation of HIV-1 have focused attention on the potential therapeutic use of iron chelators," according to B.S. Vanasbeck and colleagues at the University of Utrecht.
Writing in the Journal of Clinical Virology, Vanasbeck et al. described how iron removal can be used to hamstring HIV replication. Reactive oxygen species produced by iron can impair the activity of nuclear...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.